[Br-76]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice

Citation
Je. Ryser et al., [Br-76]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice, NUCL MED BI, 26(6), 1999, pp. 673-679
Citations number
39
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
26
Issue
6
Year of publication
1999
Pages
673 - 679
Database
ISI
SICI code
0969-8051(199908)26:6<673:[APTFT>2.0.ZU;2-T
Abstract
5-Bromo-2'-deoxyuridine (BrUdR) labeled with Br-77 and Br-76 was compared w ith 5-iodo-2'-deoxyuridine (IUdR) labeled with I-125 Or I-131, first in vit ro then in in vivo experiments in mice. The results showed a significantly higher incorporation of BrUdR into DNA than IUdR, which can be explained by the greater similarity (size and surface hydrophilicity of the molecules) of BrUdR to thymidine. Both tracers are dehalogenated quickly in vivo but n ot in vitro. Free bromide is excreted more slowly than iodide, resulting in a higher background activity level after the application of [Br-76]BrUdR a nd compensates for the favorable DNA incorporation. Br-76 has more favorabl e properties than I-124 for imaging purposes with positron emission tomogra phy (PET) because of a very convenient half-life (16 h vs. 4.15 days) and a bout double the positron yield per decay, However, the more favorable physi cal properties are balanced by the slower excretion and thus the estimated radiation dose is higher in the case of Br-76 than I-124. Thus, both tracer s, [I-124]IUdR and [Br-76]BrUdR are potentially suitable but not optimal to measure cell proliferation in vivo. The difference between the two tracers is small and the extrapolation from mice to human difficult, and thus it c annot be concluded if one of the tracers would be better than the other for imaging of cancer patients. NUCL MED BIOL 26;6:673-679, 1999. (C) 1999 Els evier Science Inc. All rights reserved.